We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Roche Diagnostics and Protedyne Sign Global Agreement

By Biotechdaily staff writers
Posted on 12 Feb 2007
Roche Diagnostics (Indianapolis, In, USA) and Protedyne (Windsor, CT, USA), a company offering industrial robotic solutions, are bringing together their latest technologies for the benefit of scientists worldwide. More...
In a collaborative effort, the two companies have integrated their technologies to provide a rapid and completely automated solution for high throughput quantitative polymerase chain reaction (PCR) applications.

Roche's LightCycler 480 instrument is a 96- or 384-well, plate-based quantitative PCR instrument. Combining speed with accuracy, the LightCycler 480 is a novel platform for gene-expression and mutation analysis. Based on innovative hardware and software, the LightCycler 480 instrument meets the needs of a broad range of genomic applications. The instrument builds upon the sensitivity and accuracy of the well-established LightCycler System, and now enables rapid high throughput quantitative PCR.

Protedyne's Radius is a new benchtop robotic system using the principles of industrial automation to offer high levels of flexibility, reproducibility, and process control for today's laboratories. Its radial design and vertical construction provide maximum functionality that can access areas of the bench top beyond its own footprint for simple and cost-effective device integration. The Radius system uses Protedyne's software that easily adapts to multiple protocols--and SmartTools, easily interchangeable tools with built-in microprocessors that store tool calibration information and track performance data.

Protedyne's Radius was a logical choice for the LightCycler 480 System as our technology provides the efficiency and throughput needed for highly- reproducible preparation across a broad range of scientific applications in genomics research, said Fran Tuttle, president and CEO of Protedyne. By combining the two systems, we can deliver to our customers exactly the throughput they are trying to achieve.



Related Links:
Roche Diagnostics
Protedyne

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.